VERONA PHARMA 2024 ANNUAL GENERAL MEETING RESULTS

Resolution

Votes For

% of Shares Voted

Votes Against

% of Shares Voted

Votes Withheld

1. Re-election of Lisa Deschamps

615,922,153

99.67

2,039,440

0.33

617,957,323

2. Re-election of Martin Edwards

617,654,873

99.95

309,040

0.05

617,959,643

3. Re-election of Sven Anders Ullman

590,081,657

95.49

27,882,176

4.51

617,959,563

4. Re-election of Christina Ackermann

617,786,657

99.97

169,976

0.03

617,952,363

5. Re-election of Michael Austwick

617,802,876

99.97

170,296

0.03

617,973,179

6. Adoption of UK Annual Accounts

616,905,143

99.81

1,179,344

0.19

618,080,217

7. Approval of UK Directors' Remuneration Report

593,000,121

96.00

24,709,190

4.00

617,705,041

8. Approval of UK Directors' Remuneration Report

592,664,317

95.97

24,906,426

4.03

617,566,473

9. Approval of Non-Executive Director annual remuneration increase

589,238,589

95.42

28,269,274

4.58

617,503,593

10. Appointment of auditor

603,137,815

99.97

195,320

0.03

603,328,865

11. Remuneration of auditor

618,024,719

99.99

65,608

0.01

618,086,057

12. Compensation of named Executive Officers

594,069,521

96.20

23,464,550

3.80

617,529,801

13. Authority to allot shares

588,880,425

95.31

28,995,238

4.69

617,871,393

14. Disapplication of pre-emption rights

616,327,627

99.75

1,576,996

0.25

617,900,353

A "Withheld" vote is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Verona Pharma plc published this content on 25 April 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 26 April 2024 15:41:56 UTC.